KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Capital Expenditures (2016 - 2025)

Opko Health's Capital Expenditures history spans 16 years, with the latest figure at $2.7 million for Q4 2025.

  • For Q4 2025, Capital Expenditures changed N/A year-over-year to $2.7 million; the TTM value through Dec 2025 reached $12.3 million, changed N/A, while the annual FY2025 figure was $12.3 million, 50.91% down from the prior year.
  • Capital Expenditures reached $2.7 million in Q4 2025 per OPK's latest filing, down from $3.1 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $19.6 million in Q3 2024 to a low of $2.7 million in Q4 2025.
  • Average Capital Expenditures over 5 years is $6.4 million, with a median of $5.4 million recorded in 2022.
  • Peak YoY movement for Capital Expenditures: soared 366.26% in 2024, then tumbled 84.0% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $6.7 million in 2021, then decreased by 5.85% to $6.3 million in 2022, then tumbled by 52.3% to $3.0 million in 2023, then surged by 548.48% to $19.6 million in 2024, then tumbled by 86.4% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Capital Expenditures are $2.7 million (Q4 2025), $3.1 million (Q3 2025), and $3.3 million (Q2 2025).